MMDA (drug)
| Clinical data | |
|---|---|
| Other names | 3-Methoxy-4,5-methylenedioxyamphetamine; 5-Methoxy-MDA; 5-MeO-MDA |
| Routes of administration | Oral |
| Drug class | Serotonin 5-HT2A receptor agonist; Serotonin releasing agent; Serotonergic psychedelic; Hallucinogen; Entactogen |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Onset of action | 20–45 minutes |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C11H15NO3 |
| Molar mass | 209.245 g·mol−1 |
| 3D model (JSmol) | |
| |
MMDA, also known as 3-methoxy-4,5-methylenedioxyamphetamine or as 5-methoxy-MDA, is a psychedelic and entactogen of the amphetamine family.